ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 26 Mar 2019